| 000 | 01589 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250516005519.0 | ||
| 264 | 0 | _c20110308 | |
| 008 | 201103s 0 0 eng d | ||
| 022 | _a1529-0131 | ||
| 024 | 7 |
_a10.1002/art.30108 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aIshiguro, Akira | |
| 245 | 0 | 0 |
_aTherapeutic potential of anti-interleukin-17A aptamer: suppression of interleukin-17A signaling and attenuation of autoimmunity in two mouse models. _h[electronic resource] |
| 260 |
_bArthritis and rheumatism _cFeb 2011 |
||
| 300 |
_a455-66 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAptamers, Nucleotide _xpharmacology |
| 650 | 0 | 4 |
_aArthritis, Experimental _xdrug therapy |
| 650 | 0 | 4 |
_aAutoimmunity _xdrug effects |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aEncephalomyelitis, Autoimmune, Experimental _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlucose-6-Phosphate Isomerase _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterleukin-17 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aMice, Inbred DBA |
| 650 | 0 | 4 | _aSELEX Aptamer Technique |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 700 | 1 | _aAkiyama, Taishin | |
| 700 | 1 | _aAdachi, Hironori | |
| 700 | 1 | _aInoue, Jun-ichiro | |
| 700 | 1 | _aNakamura, Yoshikazu | |
| 773 | 0 |
_tArthritis and rheumatism _gvol. 63 _gno. 2 _gp. 455-66 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/art.30108 _zAvailable from publisher's website |
| 999 |
_c20270213 _d20270213 |
||